Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) — The “Proteinase K Market Size, Share & Trends Analysis Report By Form, By Therapeutic Area, By Application, By End Use, By Region, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global proteinase K market size is expected to reach USD 7.84 billion in 2030 and is expected to grow at a CAGR of 8.5% from 2025 to 2030. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.
In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.
Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.
Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.
Proteinase K Market Report Highlights
- By form, the powder segment accounted for a dominant share in 2024. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder
- By therapeutic area, the infectious diseases segment captured the largest share in 2024. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth
- By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2024. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market
- By end-use, biotechnology companies held a leading revenue share in 2024. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies
- Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $4.78 billion |
| Forecasted Market Value (USD) by 2030 | $7.84 billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Proteinase K Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growth in Molecular Diagnostics
3.2.1.2. Rise in Genomic Research
3.2.1.3. Increasing Adoption in Forensic Science
3.2.2. Market restraint analysis
3.2.2.1. Availability of Alternative Enzymes
3.3. Proteinase K Market Analysis Tools
3.3.1. Industry Analysis -Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Proteinase K Market: Form Estimates & Trend Analysis
4.1. Form Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Proteinase K Market by Form Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Powder
4.4.2. Liquid
Chapter 5. Proteinase K Market: Therapeutic Area Estimates & Trend Analysis
5.1. Therapeutic Area Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Proteinase K Market by Therapeutic Area Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Infectious Diseases
5.4.2. Diabetes
5.4.3. Oncology
5.4.4. Cardiology
5.4.5. Nephrology
5.4.6. Autoimmune Diseases
5.4.7. Neurology
5.4.8. Others
Chapter 6. Proteinase K Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Proteinase K Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Isolation and Purification of Genomic DNA & RNA
6.4.2. In Situ Hybridization
6.4.3. Mitochondria Isolation
Chapter 7. Proteinase K Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global Proteinase K Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Contract Research Organization
7.4.2. Academic Institutes
7.4.3. Biotechnology Companies
7.4.4. Diagnostic Laboratories
Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.6. Europe
8.7. Asia Pacific
8.8. Latin America
8.9. MEA
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Key company market share analysis, 2024
- Merck KGaA
- Qiagen
- Thermo Fisher Scientific
- F. Hoffmann-la Roche
- Abcam
- Agilent Technologies
- Biocatalysts
- Minerva Biolabs
- Promega
- Takara Bio
- New England Biolabs
- MP Biomedicals
For more information about this report visit https://www.researchandmarkets.com/r/34wd9y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
